The GLP-1 Analogue Lixisenatide Decreases Atherosclerosis in Insulin-Resistant Mice by Modulating Macrophage Phenotype
These metabolic shifts can cause temporary blood sugar fluctuations, especially in the adjustment period
The Medicare GLP-1 Bridge launches July 2026 at a $50/mo copay for eligible Part D beneficiaries
During the 68-week experiment, those who got Semaglutide/L-Carnitine lost an average of 15% of their starting weight, or roughly 33 pounds
If you or a member of your family received semaglutide injections for weight loss and experienced side effects like gastroparesis (stomach paralysis), persistent vomiting, nausea, or diarrhea, you may qualify for an Ozempic lawsuit
Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies